Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area, By Route of Administration, By End User By Region and Competition, 2020-2030F

Description

The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encompasses the specialized practice of pharmacists creating tailored medications for individual patients, addressing unique therapeutic requirements that are not fulfilled by mass-produced pharmaceuticals. This customization may involve specific dosage forms, allergen removal, or enhanced palatability.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 12.98 Billion
Market Size 2030	USD 18.96 Billion
CAGR 2025-2030	6.52%
Fastest Growing Segment	Pain Management
Largest Market	North America

Key Market Drivers

The increasing demand for personalized medication is a primary catalyst for the Global Compounding Pharmacy Market. Patients frequently require pharmaceutical formulations precisely adjusted for specific allergies, unique dosage strengths, or alternative administration routes not commercially available. This customization is crucial for optimizing therapeutic outcomes and minimizing adverse reactions, driving demand for tailored solutions. According to the Alliance for Pharmacy Compounding, in their "2023-2024 Compounding Pharmacy Snapshot" published in July 2024, in the median hybrid pharmacy, 3% of all prescriptions were for compounded medications, demonstrating significant reliance on individualized preparations.

Key Market Challenges

The stringent and evolving regulatory environment presents a significant challenge to the global compounding pharmacy market. Varying jurisdictional oversight and complex compliance requirements for quality assurance and safety impose considerable operational complexities and financial burdens on compounding pharmacies. These escalating demands directly impede market expansion by increasing operating costs and diverting resources from potential growth initiatives. For instance, according to the Alliance for Pharmacy Compounding, in Fall 2023, 15% of all surveyed compounding pharmacies ceased hazardous drug compounding due to compliance costs associated with new USP Chapter <800> standards.

Key Market Trends

Advanced Compounding Technology Integration is a key driver for market growth, emphasizing the adoption of automation, robotics, and sophisticated software within compounding pharmacies. This integration aims to enhance precision, reduce the potential for human error, and improve overall operational efficiency, which is crucial for handling complex formulations and increasing production volumes while adhering to stringent quality standards. This trend supports pharmacies in meeting the evolving demands for customized medications. According to the Alliance for Pharmacy Compounding's demographic survey in Fall 2023, 529 unique 503A compounding pharmacies or 503B outsourcing facilities were represented, underscoring the significant number of entities potentially benefiting from these technological advancements.

Key Market Players

Wedgewood Pharmacy
B. Braun Medical Inc.
Fagron NV
Fresenius Kabi
Clinigen Group PLC
Dougherty's Pharmacy, Inc.
Lorraine's Pharmacy
Rx3 Compounding Pharmacy
Institutional Pharmacy Solutions
Mcguff compounding pharmacy services

Report Scope:

In this report, the Global Compounding Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Compounding Pharmacy Market, By Therapeutic Area:

Pain Management
Hormone Replacement
Dermal Disorders
Nutritional Supplements
Other Therapeutic Areas

Compounding Pharmacy Market, By Route of Administration:

Oral
Topical
Parenteral
Other Route of Administrations

Compounding Pharmacy Market, By End User:

Humans
Veterinary

Compounding Pharmacy Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Compounding Pharmacy Market.

Available Customizations:

Global Compounding Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Compounding Pharmacy Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas)
- 5.2.2. By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations)
- 5.2.3. By End User (Humans, Veterinary)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Compounding Pharmacy Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Therapeutic Area
- 6.2.2. By Route of Administration
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Compounding Pharmacy Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Therapeutic Area
    - 6.3.1.2.2. By Route of Administration
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Compounding Pharmacy Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Therapeutic Area
    - 6.3.2.2.2. By Route of Administration
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Compounding Pharmacy Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Therapeutic Area
    - 6.3.3.2.2. By Route of Administration
    - 6.3.3.2.3. By End User

7. Europe Compounding Pharmacy Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Therapeutic Area
- 7.2.2. By Route of Administration
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Compounding Pharmacy Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Therapeutic Area
    - 7.3.1.2.2. By Route of Administration
    - 7.3.1.2.3. By End User
- 7.3.2. France Compounding Pharmacy Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Therapeutic Area
    - 7.3.2.2.2. By Route of Administration
    - 7.3.2.2.3. By End User
- 7.3.3. United Kingdom Compounding Pharmacy Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Therapeutic Area
    - 7.3.3.2.2. By Route of Administration
    - 7.3.3.2.3. By End User
- 7.3.4. Italy Compounding Pharmacy Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Therapeutic Area
    - 7.3.4.2.2. By Route of Administration
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Compounding Pharmacy Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Therapeutic Area
    - 7.3.5.2.2. By Route of Administration
    - 7.3.5.2.3. By End User

8. Asia Pacific Compounding Pharmacy Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Therapeutic Area
- 8.2.2. By Route of Administration
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Compounding Pharmacy Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Therapeutic Area
    - 8.3.1.2.2. By Route of Administration
    - 8.3.1.2.3. By End User
- 8.3.2. India Compounding Pharmacy Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Therapeutic Area
    - 8.3.2.2.2. By Route of Administration
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Compounding Pharmacy Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Therapeutic Area
    - 8.3.3.2.2. By Route of Administration
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Compounding Pharmacy Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Therapeutic Area
    - 8.3.4.2.2. By Route of Administration
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Compounding Pharmacy Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Therapeutic Area
    - 8.3.5.2.2. By Route of Administration
    - 8.3.5.2.3. By End User

9. Middle East & Africa Compounding Pharmacy Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Therapeutic Area
- 9.2.2. By Route of Administration
- 9.2.3. By End User
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Compounding Pharmacy Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Therapeutic Area
    - 9.3.1.2.2. By Route of Administration
    - 9.3.1.2.3. By End User
- 9.3.2. UAE Compounding Pharmacy Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Therapeutic Area
    - 9.3.2.2.2. By Route of Administration
    - 9.3.2.2.3. By End User
- 9.3.3. South Africa Compounding Pharmacy Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Therapeutic Area
    - 9.3.3.2.2. By Route of Administration
    - 9.3.3.2.3. By End User

10. South America Compounding Pharmacy Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Therapeutic Area
- 10.2.2. By Route of Administration
- 10.2.3. By End User
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Compounding Pharmacy Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Therapeutic Area
    - 10.3.1.2.2. By Route of Administration
    - 10.3.1.2.3. By End User
- 10.3.2. Colombia Compounding Pharmacy Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Therapeutic Area
    - 10.3.2.2.2. By Route of Administration
    - 10.3.2.2.3. By End User
- 10.3.3. Argentina Compounding Pharmacy Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Therapeutic Area
    - 10.3.3.2.2. By Route of Administration
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Compounding Pharmacy Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Wedgewood Pharmacy
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. B. Braun Medical Inc.
15.3. Fagron NV
15.4. Fresenius Kabi
15.5. Clinigen Group PLC
15.6. Dougherty's Pharmacy, Inc.
15.7. Lorraine's Pharmacy
15.8. Rx3 Compounding Pharmacy
15.9. Institutional Pharmacy Solutions
15.10. Mcguff compounding pharmacy services